Bioequivalence and Bioavailability Forum • ANVISA guidelines for two-stage design

ANVISA guidelines for two-stage design [Two-Stage / GS Designs]

posted by Mauricio Sampaio – Brazil, 2020-02-12 18:04 (2312 d 11:44 ago) – Posting: # 21166
Views: 13,308

Hi nobody

❝ "Ermmm...... WHAT???? :-D :party: '

Sorry! Change to: unknowlegement of intra-individual variability

Complete thread:

ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-11 20:52
- Brainless copy-and-paste-devil Helmut 2020-02-12 02:26
  - Brainless copy-and-paste-devil Mauricio Sampaio 2020-02-12 17:33
- ANVISA guidelines for two-stage design ElMaestro 2020-02-12 08:27
  - ANVISA guidelines for two-stage design nobody 2020-02-12 08:49
  - ANVISA guidelines for two-stage design Helmut 2020-02-12 13:12
  - ANVISA guidelines for two-stage designMauricio Sampaio 2020-02-12 17:04
  - ANVISA guidelines for two-stage design Mauricio Sampaio 2020-02-12 17:11
- ANVISA guidelines for two-stage design ElMaestro 2020-02-12 21:54
  - crap Helmut 2020-02-15 17:53
    - crap Mauricio Sampaio 2020-02-16 05:01
      - crap Helmut 2020-02-16 15:43
        
        crap d_labes 2020-02-16 19:34
        
        Explained crap remains crap Helmut 2020-02-17 12:49
        
        Proposed changes Mauricio Sampaio 2020-02-17 13:50
        
        Proposed changes Helmut 2020-02-17 14:16

Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
111 visitors (0 registered, 111 guests [including 28 identified bots]).
Forum time: 06:49 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking. Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz